Joint Inflammation NewsLatest News On Joint Inflammation Upadacitinib Improves Giant Cell Arteritis in Phase 3 Trial6/14/2024 4:48 AM Rheumatoid Arthritis Disease Activity Impacts Severity of Associated Interstitial Lung Disease6/13/2024 12:55 AM FDA OKs Sarilumab for Polyarticular Juvenile Idiopathic Arthritis6/11/2024 1:53 PM Having More Tender Than Swollen Joints Worsens Outcomes in Early Rheumatoid Arthritis6/7/2024 5:31 AM Over-the-Counter Arthritis Supplements Pose Adrenal Danger6/6/2024 6:18 AM Celiac Disease: Five Things to Know6/6/2024 3:49 AM High Steroid Dose in Lupus Nephritis Improves Outcome but Increases Risk5/30/2024 2:12 AM Nipocalimab's Unique Mechanism Gets Second Chance in Rheumatoid Arthritis5/13/2024 5:16 AM Several Novel Injectables Show Early Promise in Knee Osteoarthritis5/7/2024 4:52 AM Most Patients With Rheumatoid Arthritis Meet European Medicines Agency's Janus Kinase Inhibitor Warning Criteria5/3/2024 3:57 AM Lower CVD Risk With Stable DMARD Therapy in Seropositive Rheumatoid Arthritis5/1/2024 10:44 PM Reasons for Heightened Thrombotic Risk in Rheumatoid Arthritis Remain Unclear4/30/2024 5:08 AM Two Biosimilars Approved in Europe for Autoimmune Disorders4/26/2024 10:17 AM Rheumatology Data Reflect Poor Adoption of ICD-104/26/2024 5:34 AM Sinonasal Symptoms Help Predict Granulomatosis With Polyangiitis Relapse4/22/2024 1:57 AM The Patient Knows Best: PROs in RA Practice and Research4/22/2024 1:01 AM Shared Telehealth Brings Rheumatology Care to Rural Areas4/18/2024 2:43 AM FDA Approves Second Ustekinumab Biosimilar4/17/2024 5:01 PM Modifying Gut Microbiota May Enhance DMARD Efficacy in RA4/17/2024 5:23 AM Guselkumab Provides Long-Term Relief From Psoriatic Arthritis Symptoms4/17/2024 1:32 AM